Boeing : Resistance levels that will be difficult to break
Entry price | Target | Stop-loss | Potential |
---|
$368 |
$322 |
$397 |
+12.5% |
---|
Up substantially over the past few weeks, shares in Boeing Company (The) should pause in their rise close to the major resistance around 395.86 USD.
Summary● The company has poor fundamentals for a short-term investment strategy.
Strengths● The group usually releases upbeat results with huge surprise rates.
Weaknesses● The stock is close to a major daily resistance at USD 395.86, which should be gotten rid of so as to gain new appreciation potential.
● With an expected P/E ratio at 66.04 and 15.64 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
● The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
● Analysts covering the stock have recently lowered their earnings forecast.
● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.